Chordia Therapeutics, Free, etc.

<190A> Chordia Therapeutics Co., Ltd. Nomura Spark Investment Co., Ltd. Shareholding Ratio: -% -> 7.71% Reporting Obligation Date: 2024/06/14 <190A> Chordia Therapeutics Co., Ltd. Kyoto University Innovation Capital Co., Ltd. Shareholding Ratio: -% -> 12.14% Reporting Obligation Date: 2024/06/14 <190A> Chordia Therapeutics Co.

Fisco Japan19:50 ET

GENDA, Hakuten, etc. [Emerging Markets Press Release]

＜2173＞Preparing for Hakuten Tokyo Stock Exchange Standard Market Classification Change Application＜5138＞Acquired shares of LibertyShip, which handles area development etc. in the Aoshima area of Miyazaki City, and made it an affiliate company applying the equity method ＜9166＞GenDA consolidated subsidiary Dynamo Amusement takes over the VR game business

Fisco JapanMay 23 18:30 ET

Check out the disclosed information for [Tomorrow's Good and Bad Materials]! (Announced on 5/23)

[Good Material] ――――――――――■Cruise [Tokyo Stock Exchange S] The token (FCT) of the new blockchain game “Ergosm” will be listed on the crypto asset exchange “MEXC Global.” ■Hakuten [Tokyo Stock Exchange G] We will proceed with preparations for applying for a market classification change to the Tokyo Stock Exchange Standard Market. ■Mitachi Sangyo [Tokyo Stock Exchange S] revised dividend for the current fiscal year by 5 yen. ■Delica Foods Holdings [Tokyo Stock Exchange S

MinkabuMay 23 07:00 ET

REBASE: Full year financial results presentation materials for the fiscal year ending 2024/3

JPXMay 14 02:05 ET · Announcements

REBASE: Notice regarding differences between full-year earnings forecasts and actual values

JPXMay 14 02:05 ET · Announcements

REBASE: Summary of financial results for the fiscal year ending 2024/3 [Japanese GAAP] (unconsolidated)

JPXMay 14 02:05 ET · Announcements